Authors: Videbaek, C Toska, K Friberg, L Holm, S Angelo, HR Knudsen, GM

Citation: C. Videbaek et al., In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by[I-123]IBZM and single photon emission computed tomography, J CEREBR B, 21(1), 2001, pp. 92-97

Authors: Pinborg, LH Videbaek, C Hasselbalch, SG Sorensen, SA Wagner, A Paulson, OB Knudsen, GM

Citation: Lh. Pinborg et al., Benzodiazepine receptor quantification in Huntington's disease with [I-123]iomazenil and SPECT, J NE NE PSY, 70(5), 2001, pp. 657-661

Authors: Videbaek, C Toska, K Scheideler, MA Paulson, OB Knudsen, GM

Citation: C. Videbaek et al., SPECT tracer [I-123]IBZM has similar affinity to dopamine D2 and D3 receptors, SYNAPSE, 38(3), 2000, pp. 338-342

Authors: Pinborg, LH Videbaek, C Knudsen, GM Swahn, CG Halldin, C Friberg, L Paulson, OB Lassen, NA

Citation: Lh. Pinborg et al., Dopamine D-2 receptor quantification in extrastriatal brain regions using [I-123]epidepride with bolus/infusion, SYNAPSE, 36(4), 2000, pp. 322-329

Authors: Videbaek, C Ott, P Paulson, OB Knudsen, CM

Citation: C. Videbaek et al., Blood-brain barrier transport and protein binding of flumazenil and iomazenil in the rat: Implications for neuroreceptor studies, J CEREBR B, 19(9), 1999, pp. 948-955

Authors: Hasselbalch, SG Knudsen, GM Videbaek, C Pinborg, LH Schmidt, JF Holm, S Paulson, OB

Citation: Sg. Hasselbalch et al., No effect of insulin on glucose blood-brain barrier transport and cerebralmetabolism in humans, DIABETES, 48(10), 1999, pp. 1915-1921